Works matching AU Peloquin, Charles A.

Results: 121
    1

    Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2025, v. 211, n. 7, p. 1277, doi. 10.1164/rccm.202407-1354OC
    By:
    • Phillips, Patrick P. J.;
    • Peloquin, Charles A.;
    • Sterling, Timothy R.;
    • Kaur, Pawandeep;
    • Diacon, Andreas H.;
    • Gotuzzo, Eduardo;
    • Benator, Debra;
    • Warren, Robin M.;
    • Sikes, David;
    • Lecca, Leonid;
    • Gandhi, Neel R.;
    • Streicher, Elizabeth M.;
    • Dianis, Nancy;
    • Eisenach, Kathleen;
    • Mitnick, Carole D.;
    • Horsburgh Jr., C. Robert
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    The Treatment of Tuberculosis.

    Published in:
    Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 6, p. 1455, doi. 10.1002/cpt.2261
    By:
    • Peloquin, Charles A.;
    • Davies, Geraint R.
    Publication type:
    Article
    13

    Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity.

    Published in:
    Pharmacotherapy, 2023, v. 43, n. 1, p. 6, doi. 10.1002/phar.2744
    By:
    • Venugopalan, Veena;
    • Casaus, Danielle;
    • Kainz, Leonie;
    • Slaton, Cara N.;
    • Hurst, Natalie;
    • Bruzzone, Maria;
    • Hu, Calvin;
    • Sword, Gabriel;
    • Cherabuddi, Kartikeya;
    • Iovine, Nicole;
    • Liu, Jiajun;
    • Scheetz, Marc H.;
    • Rhodes, Nathaniel;
    • Maranchick, Nicole;
    • Peloquin, Charles A.;
    • Klinker, Kenneth;
    • Alshaer, Mohammad H.
    Publication type:
    Article
    14

    Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 2, p. 104, doi. 10.1093/jpids/piaa024
    By:
    • Szipszky, Claire;
    • Aartsen, Daniel Van;
    • Criddle, Sarah;
    • Rao, Prakruti;
    • Zentner, Isaac;
    • Justine, Museveni;
    • Mduma, Estomih;
    • Mpagama, Stellah;
    • Al-Shaer, Mohammad H;
    • Peloquin, Charles;
    • Thomas, Tania A;
    • Vinnard, Christopher;
    • Heysell, Scott K
    Publication type:
    Article
    15

    Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 1, p. 14, doi. 10.1093/jpids/piy106
    By:
    • Justine, Museveni;
    • Yeconia, Anita;
    • Nicodemu, Ingi;
    • Augustino, Domitila;
    • Gratz, Jean;
    • Mduma, Estomih;
    • Heysell, Scott K;
    • Kivuyo, Sokoine;
    • Mfinanga, Sayoki;
    • Peloquin, Charles A;
    • Zagurski, Theodore;
    • Kibiki, Gibson S;
    • Mmbaga, Blandina;
    • Houpt, Eric R;
    • Thomas, Tania A
    Publication type:
    Article
    16

    Pharmacokinetics of First-Line Antituberculosis Drugs Using WHO Revised Dosage in Children With Tuberculosis With and Without HIV Coinfection.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2016, v. 5, n. 4, p. 356, doi. 10.1093/jpids/piv035
    By:
    • Kwara, Awewura;
    • Enimil, Anthony;
    • Gillani, Fizza S.;
    • Hongmei Yang;
    • Sarfo, Anima M.;
    • Dompreh, Albert;
    • Ortsin, Antoinette;
    • Osei-Tutu, Lawrence;
    • Owusu, Sandra Kwarteng;
    • Wiesner, Lubbe;
    • Norman, Jennifer;
    • Kurpewski, Jaclynn;
    • Peloquin, Charles A.;
    • Ansong, Daniel;
    • Antwi, Sampson
    Publication type:
    Article
    17

    Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2014, v. 3, n. 2, p. 132, doi. 10.1093/jpids/pit077
    By:
    • Weiner, Marc;
    • Savic, Radojka M.;
    • Kenzie, William R. Mac;
    • Wing, Diane;
    • Peloquin, Charles A.;
    • Engle, Melissa;
    • Bliven, Erin;
    • Prihoda, Thomas J.;
    • Gelfond, Jonathan A. L.;
    • Scott, Nigel A.;
    • Abdel-Rahman, Susan M.;
    • Kearns, Gregory L.;
    • Burman, William J.;
    • Sterling, Timothy R.;
    • Villarino, M. Elsa
    Publication type:
    Article
    18
    19
    20

    A Single-Run HPLC–MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.

    Published in:
    Pharmaceutics, 2023, v. 15, n. 11, p. 2543, doi. 10.3390/pharmaceutics15112543
    By:
    • Köhler, Niklas;
    • Karaköse, Hande;
    • Grobbel, Hans-Peter;
    • Hillemann, Doris;
    • Andres, Sönke;
    • König, Christina;
    • Kalsdorf, Barbara;
    • Brehm, Thomas Theo;
    • Böttcher, Laura;
    • Friesen, Inna;
    • Hoffmann, Harald;
    • Strelec, Dražen;
    • Schaub, Dagmar;
    • Peloquin, Charles A.;
    • Schmiedel, Stefan;
    • Decosterd, Laurent A.;
    • Choong, Eva;
    • Wicha, Sebastian G.;
    • Aarnoutse, Rob E.;
    • Lange, Christoph
    Publication type:
    Article
    21

    Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 1053, doi. 10.1093/cid/ciad312
    By:
    • Haley, Connie A;
    • Schechter, Marcos C;
    • Ashkin, David;
    • Peloquin, Charles A;
    • Cegielski, J Peter;
    • Andrino, Barbara B;
    • Burgos, Marcos;
    • Caloia, Lori A;
    • Chen, Lisa;
    • Colon-Semidey, Angel;
    • DeSilva, Malini B;
    • Dhanireddy, Shireesha;
    • Dorman, Susan E;
    • Dworkin, Felicia F;
    • Hammond-Epstein, Heidi;
    • Easton, Alice V;
    • Gaensbauer, James T;
    • Ghassemieh, Bijan;
    • Gomez, Maria E;
    • Horne, David
    Publication type:
    Article
    22

    Reply to Upton et al.

    Published in:
    2023
    By:
    • Kempker, Russell R;
    • Kipiani, Maia;
    • Peloquin, Charles A
    Publication type:
    Letter to the Editor
    23
    24
    25
    26
    27

    Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2020, v. 201, n. 3, p. 313, doi. 10.1164/rccm.201905-0990OC
    By:
    • Kim, Michael D.;
    • Baumlin, Nathalie;
    • Makoto Yoshida;
    • Polineni, Deepika;
    • Salathe, Sebastian F.;
    • David, Joseph K.;
    • Peloquin, Charles A.;
    • Wanner, Adam;
    • Dennis, John S.;
    • Sailland, Juliette;
    • Whitney, Philip;
    • Horrigan, Frank T.;
    • Sabater, Juan R.;
    • Abraham, William M.;
    • Salathe, Matthias
    Publication type:
    Article
    28
    29

    Reply to te Brake et al.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2019, v. 199, n. 9, p. 1167, doi. 10.1164/rccm.201812-2281LE
    By:
    • Velásquez, Gustavo E.;
    • Brooks, Meredith B.;
    • Sánchez Garavito, Epifanio;
    • Calderón, Roger I.;
    • Jiménez, Judith;
    • Tintaya, Karen;
    • Peloquin, Charles A.;
    • Osso, Elna;
    • Lecca, Leonid;
    • Davies, Geraint R.;
    • Mitnick, Carole D.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.

    Published in:
    Antibiotics (2079-6382), 2021, v. 10, n. 6, p. 739, doi. 10.3390/antibiotics10060739
    By:
    • Rao, Prakruti S.;
    • Moore, Christopher C.;
    • Mbonde, Amir A.;
    • Nuwagira, Edwin;
    • Orikiriza, Patrick;
    • Nyehangane, Dan;
    • Al-Shaer, Mohammad H.;
    • Peloquin, Charles A.;
    • Gratz, Jean;
    • Pholwat, Suporn;
    • Arinaitwe, Rinah;
    • Boum, Yap;
    • Mwanga-Amumpaire, Juliet;
    • Houpt, Eric R.;
    • Kagan, Leonid;
    • Heysell, Scott K.;
    • Muzoora, Conrad
    Publication type:
    Article
    41
    42

    Tuberculosis therapy for 2016 and beyond.

    Published in:
    Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 14, p. 1859, doi. 10.1080/14656566.2016.1215428
    By:
    • Lauzardo, Michael;
    • Peloquin, Charles A.
    Publication type:
    Article
    43
    44
    45
    46
    47

    Noninvasive <sup>11</sup>C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 470, p. 1, doi. 10.1126/scitranslmed.aau0965
    By:
    • Tucker, Elizabeth W.;
    • Guglieri-Lopez, Beatriz;
    • Ordonez, Alvaro A.;
    • Ritchie, Brittaney;
    • Klunk, Mariah H.;
    • Sharma, Richa;
    • Chang, Yong S.;
    • Sanchez-Bautista, Julian;
    • Frey, Sarah;
    • Lodge, Martin A.;
    • Rowe, Steven P.;
    • Holt, Daniel P.;
    • Gobburu, Jogarao V. S.;
    • Peloquin, Charles A.;
    • Mathews, William B.;
    • Dannals, Robert F.;
    • Pardo, Carlos A.;
    • Kannan, Sujatha;
    • Ivaturi, Vijay D.;
    • Jain, Sanjay K.
    Publication type:
    Article
    48
    49
    50